Assessing the Safety, Performance, and User Experience of the Tandem Mobi Automated Insulin Delivery System Among Young Competitive Athletes in Real-world Settings.
This record was last updated May 25, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
A single arm, interventional study with 12 weeks study phase preceded by a 2-week run in phase, aiming to evaluate the effectiveness and applicability of the Tandem Mobi automated insulin delivery system (Tandem Mobi Pump System) for competitive youth athletes with type 1 diabetes in real-world conditions.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-13.